Genuit Share Discussion Threads

[ianguerin] 05/4/2023 07:45

Pullen appointed as COO in Nov 2021 & is not being replaced !

[paddy easom] 11/1/2023 14:06

So where do we see this going.

[km18] 16/8/2022 14:40

Genuit posted Interims for the 6 months ended June 30th 2022 this morning. The Group performed reasonably in the HY period with revenues up 7.6% to £318m, PBT down 2.7% to £32.9m and EPS up 27.6% to 10.1p. According to Joe Vorih, CEO, “Agile pricing leadership offset inflationary pressures, and the effect of selective business decisions helped to increase our margins. While mindful of the macroeconomic pressures, we have good momentum as we enter the second half, and the Group anticipates meeting full year expectations.” These are for high single digit revenue growth and widening margins. However, consensus market estimates for FY22 EPS at 33.7p look too aggressive. Valuation is also a little unhelpful with forward PE ratio at 12.4x in the bottom quartile for the sector. Share price is also still in a 12-month correction for now. GEN is a share to monitor for now...

...from WealthOracle

[baddeal] 17/3/2022 10:31

Peel hunt new tp 590

[km18] 18/2/2022 13:37

...from last year...

Company overview:
Genuit Group is actually the new name of Polypipe Group plc. They provide sustainable solutions for water, climate and ventilation management. Sustainability is at the core of the firm’s strategy, driven by constant innovations. Genuit benefits from the active plans of governments across the globe to achieve net zero strategies and promote ESG activities and foresees geographic reach to be a major driver of growth for the group in the long term.
Blended approach for growth, with several acquisitions and continuous Capex seems to be working for the company in the long run, as both revenues and EPS have been growing steadily over the past 6 years, with the sole exception the catharsis of 2020. Fundamentally the company is also supported by a solid history of debt retirement and cash generation.
the half-year report sounds very promising. The group revenue was 32.5% above the 2019 figure (yes, that is a 3rd above the covid free year), driven by a significant raise in residential business at £183.8m (64% growth yoy lfl basis). The sole red flag on the report comes in the face of pressured margins, coming from the rising input costs. This has been balanced very nicely by 8% increase in prices for final customers, which proves the company’s brand recognition.  The labour supply issues several sectors are experiencing seems to be fading at Genuit, but we suggest keeping your eyes open for September for further guidance on the direction of the “pingdemic”. Genuit’s exposure to pen air projects is what supported the performance during the lockdowns, but the group saw drop in the commercial side of the sector. So, overall growth there is mediocre at 8.3%. Analyst consensus is expecting 9% increase in profit, built on the residentials and the acquisitions which are performing quite well. The board is expecting “underlying operating profit for FY to be ahead of expectations”....from WealthOracleAM

[baddeal] 16/11/2021 17:25

Results were ok it was more the indication of tightening margins that I think has caused concern. Prior to the drop they were trading c19pe so pretty aggressive valuation imo.

[dope007] 16/11/2021 15:48

They look ok but the stock is not cheap either

[scooper72] 16/11/2021 15:43

Looks like Aberdeen Standard Investments who hold 10.96 percent have cut their holding by about 10 percent and sold 2.3M shares last month. And I guess there must be others with large holding taking some profits. I'm now down an annoying 14 percent on my current holding in my SIPP having sold out previously at 688p with my original larger holding in my ISA. But thinking it is a bit late to comfortably take the £300 loss without worrying about doubly kicking myself if the price recovers. Today's drop seems hard to understand when considering the results out this morning looked ok

[dope007] 16/11/2021 10:29

Input costs are definitely not past their peak. Additionally the industry is seeing further raw material shortage issues.

Order books are full but at some point these horrendous input price rises are going to lead to reducing orders. However Genuit are in a better place than the window boys with less reliance on the home replacement mkt were at some point a home owner is going to say nope, not paying that...

[roguetraderuk] 16/11/2021 09:15

think these are ones to watch here. going forward they have a good growth run rate as they are going to ride the greening of infrastructure new and old. as for the high input costs, there are signs its past its peak in many commodities. also spot freight rates have been coming down in recent weeks, so while still high, mean things are going in the right direction. there is some critical support for the shares around current levels, which if broken might mean a trip to 550/560, where i think they would be very attractive.

[scooper72] 16/11/2021 08:32

Do you see these factors averaging out in terms of when they announce their profits or do you see the share price pulling back further on results whenever they come out. Ok kicking myself for going back in a bit early and just wondering where fair value is currently.

[dope007] 13/10/2021 13:12

Like the rest of our industry 2 dynamics are at play

1) Raw mat massive price hikes and ongoing/rolling shortages

2) High demand so selling everything they can produce even at higher prices

[scooper72] 13/10/2021 12:14

Just bought back in. Looks like the trend might just be moving back in the right direction

[philanderer] 08/10/2021 14:24

Just a guess, sometime late november.

[grizzlysidders] 08/10/2021 14:11

This has taken a bit of a battering of late.Anyone know when the next trading update is due?The last one was the 20th of May.

[philanderer] 16/9/2021 10:54

As long as they don't start buying Lear jets and works of art ;-)


"...Genuit Group, the sustainable water and climate management solutions business, formerly known as Polypipe, is moving its headquarters out of South Yorkshire.

"The Business Masters award winning company has taken a ten year lease on 11,750 sq ft at 4 Victoria Place in the South Bank district of Leeds city centre, which is owned by Medical Protection Society (MPS).

"The move was described by the company’s chief executive officer, Martin Payne as being designed to enable “colleagues on site in Doncaster to continue to expand”.

[philanderer] 01/9/2021 16:49

😀👍🏼

[baddeal] 01/9/2021 15:45

Nice milestone today

[philanderer] 30/8/2021 00:13

xd thursday morning for the 4p dividend.

[keyno] 27/8/2021 11:45

Past couple of month's climb rather too fast and furious for my liking so sold some today.

[arja] 24/8/2021 10:07

is the p/e ratio really 89 as shown on ADVFN financials ? Tempted to buy for short term trade as chart looks great and a NOR situation - not sure now !

[philanderer] 19/8/2021 15:04

Yesterday seems to have shaken the loose holders out.

[philanderer] 19/8/2021 10:49

Yesterday's Deutsche note..


(Sharecast News) - Analysts at Deutsche Bank raised their target price on plastic piping manufacturer Genuit from 653.0p to 708.0p on Wednesday, citing the group's "strong" first-half performance

Deutsche Bank pointed to Genuit's adjusted interim operating profit of £48.6m, eclipsing its 2019 first-half performance by roughly 24% as it primary reason for the upgrade but also noted that the company appeared to be continuing to trade well, prompting a rise in management's expectations for the full year.

"We raise our 2021-2023E operating profit forecasts by 4-7% and our target price by circa 8%," said the German bank, which also reiterated its 'buy' rating on the stock.

"The company remains a strong performer, with recent acquisitions operating at or above expectations (three in February alone indicative of a team that does not let the grass grow under its feet)."

[keyno] 18/8/2021 22:20

More buy recommendations should be on the way. Such a pity the company saw fit to change its name. Genuit sounds as if it's a pharmaceutical company.